Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
32.24 MXN
39.18 B MXN
133.78 B MXN
612.16 M
About CHUGAI PHARMACEUTICAL CO
Sector
CEO
Osamu Okuda
Headquarters
Tokyo
Website
Founded
1925
ISIN
JP3519400000
FIGI
BBG012VHDLP4
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange CHUGAI PHARMACEUTICAL CO., LTD stocks are traded under the ticker 4519/N.
We've gathered analysts' opinions on CHUGAI PHARMACEUTICAL CO., LTD future price: according to them, 4519/N price has a max estimate of 1,285.73 MXN and a min estimate of 584.42 MXN. Watch 4519/N chart and read a more detailed CHUGAI PHARMACEUTICAL CO., LTD stock forecast: see what analysts think of CHUGAI PHARMACEUTICAL CO., LTD and suggest that you do with its stocks.
4519/N stock is 1.03% volatile and has beta coefficient of 0.99. Track CHUGAI PHARMACEUTICAL CO., LTD stock price on the chart and check out the list of the most volatile stocks — is CHUGAI PHARMACEUTICAL CO., LTD there?
Today CHUGAI PHARMACEUTICAL CO., LTD has the market capitalization of 1.46 T, it has increased by 0.20% over the last week.
Yes, you can track CHUGAI PHARMACEUTICAL CO., LTD financials in yearly and quarterly reports right on TradingView.
CHUGAI PHARMACEUTICAL CO., LTD is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
4519/N earnings for the last quarter are 9.12 MXN per share, whereas the estimation was 8.28 MXN resulting in a 10.19% surprise. The estimated earnings for the next quarter are 7.82 MXN per share. See more details about CHUGAI PHARMACEUTICAL CO., LTD earnings.
CHUGAI PHARMACEUTICAL CO., LTD revenue for the last quarter amounts to 43.27 B MXN, despite the estimated figure of 40.63 B MXN. In the next quarter, revenue is expected to reach 38.70 B MXN.
4519/N net income for the last quarter is 15.01 B MXN, while the quarter before that showed 12.75 B MXN of net income which accounts for 17.77% change. Track more CHUGAI PHARMACEUTICAL CO., LTD financial stats to get the full picture.
CHUGAI PHARMACEUTICAL CO., LTD dividend yield was 1.50% in 2023, and payout ratio reached 40.44%. The year before the numbers were 2.32% and 34.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 18, 2025, the company has 7.60 K employees. See our rating of the largest employees — is CHUGAI PHARMACEUTICAL CO., LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHUGAI PHARMACEUTICAL CO., LTD EBITDA is 73.89 B MXN, and current EBITDA margin is 40.26%. See more stats in CHUGAI PHARMACEUTICAL CO., LTD financial statements.
Like other stocks, 4519/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHUGAI PHARMACEUTICAL CO., LTD stock right from TradingView charts — choose your broker and connect to your account.